Skip to content

Operators of So-Called Canadian Pharmacy Sentenced for Distributing Misbranded Prescription Drugs

Last year, we wrote about criminal charges against Billy Lee, Tarn Uppal, and Tony Lee, who operated "Canadian" internet pharmacies but shipped US residents drugs that were not really from Canada. This week, the FDA's Office of Criminal Investigations announced sentencing for these British Columbia residents, amounting to three years' probation and a fine of $55,000. Their Barbados-registered company, Quantum Solutions, received a $150,000 fine and was ordered to forfeit $4,235,000.

Despite the Canadian residency of the operators, there was hardly anything Canadian about Quantum. The company bought drugs made for foreign markets from suppliers in Turkey and other non-Canadian countries, and sold the drugs to pharmacists in the US. These drugs were sent to a shipper in the UK, who repackaged them and put misleading labeling on them to make them appear as if they were for the personal use of the recipient. Packages were sent into the US, where they were again repackaged. The drugs were misbranded and sent to the US pharmacists, presumably for resale. Money paid for these drugs traveled not only to Canada, but also offshore to Barbados.

By using websites that supposedly were operated by a real Canadian pharmacy and supposedly dispensed Canadian pharmaceuticals - including canadadrugpharmacy.com, canadianpharmacymeds.com, and canadadrugcenter.com - the operators deceived customers, primarily ones in the US. None of the prescription drugs sold by these websites met FDA approval because they were made and labeled for use outside of the US.

The sentencing comes only weeks after the shutdown of the flagship website of CanadaDrugs, whose operators pleaded guilty in April to selling misbranded and counterfeit prescription drugs in the US, most notably fake cancer medication sourced from outside Canada.

As proponents of the Canadian internet pharmacy sector continue to advocate for the legalization of sales of drugs from "Canadian" and other "international" internet pharmacies into the US, it's important to expose the way in which these internet pharmacies often really work - selling drugs that don't really come from Canada, which increases the safety risk.

David Khalaf is a writing, communications, and marketing professional with specialties in media, investigations, content strategy, and writing instruction. His 20 years of writing, media, and communications work have included two top-tier universities (USC and UCLA), print and digital magazines, consulting firms, and technology companies.

His current work involves content strategy and development at LegitScript, a company that helps the world's leading search engines, payment service providers, and internet platforms and marketplaces do business with legitimate, legally operating entities in more than 80 countries and 15 languages around the world. LegitScript specializes in risk and compliance for highly regulated industries including CBD/cannabis, online gambling, cryptocurrencies, drugs, financial trading, online adult, scams and fraud, and more.

Recent Blog Articles

Why LegitScript Certification Is Your Passport in 2025: A Recap for Healthcare Businesses

In a dynamic regulatory landscape where risk, reputation, and compliance increasingly determine access to financial services, healthcare businesses face a unique challenge. A recent webinar hosted by LegitScript - featuring Rob Bast, chief sales officer at Corepay, and Angela Salter, director of sal...

LegitScript & Special Guest Marketplace Risk Panel Recap: How to Stay Ahead of Global Regulations and Trends: Using Deep Intelligence to Shape Policy and Mitigate Risk

At Marketplace Risk, experts tackled the challenges of content moderation and platform responsibility, focusing on drug-related content, evolving evasion tactics, and the balance between AI and human oversight. Transparency and proactive safety measures took center stage. Listen below to an excerpt...
FDA updates REMS program for common abortion drug mifepristone.

Key Takeaways from LegitScript’s Webinar: Navigating Risks and Regulations in Online Abortion Pill Sales

The online sale of abortion medication is at the center of a rapidly evolving regulatory and risk environment. In LegitScript's June 2025 webinar, Online Abortion Pill Sales: Navigating Regulations and Problematic Activity, experts outlined how recent legal changes are reshaping access to medication...

Merchant Onboarding Essentials: What You Need to Know

Modern merchant onboarding involves much more than collecting documents - it's about building a smart, scalable risk management process that can keep up with changing technology and fraud tactics. Whether you're launching a payments platform or refining your underwriting approach, getting onboarding...